Zobrazeno 1 - 10
of 11
pro vyhledávání: '"John T. Butterfield"'
Publikováno v:
World Neurosurgery. 173:e132-e139
Autor:
John T Butterfield, Sina Golzarian, Reid Johnson, Emily Fellows, Sanjay Dhawan, Clark C Chen, Erin L Marcotte, Andrew S Venteicher
Publikováno v:
The Lancet. 400:2063-2073
Disparities in treatment and outcomes disproportionately affect minority ethnic and racial populations in many surgical fields. Although substantial research in racial disparities has focused on outcomes, little is known about how surgeon recommendat
Autor:
Rajiv Dharnipragada, John T. Butterfield, Sanjay Dhawan, Meredith E. Adams, Andrew S. Venteicher
Publikováno v:
World neurosurgery.
Tympanojugular paragangliomas (TJPs) are slow-growing tumors arising within the middle ear or jugular foramen. The development of modified skull base approaches and the increasing use of stereotactic radiosurgery have provided more modern techniques
Autor:
Andrew W. Grande, Andrew S. Venteicher, Bharathi D. Jagadeesan, John T. Butterfield, Clark C. Chen, Ramachandra P. Tummala
Publikováno v:
World Neurosurgery. 146:e1182-e1190
Background Balloon test occlusion is a widely used method for predicting tolerance of vessel occlusion in the treatment of aneurysms, fistulae, and head and neck neoplasms. However, the false-negative rate is variably reported due in part to the dive
Autor:
Andrew S. Venteicher, Daniel J. Guillaume, Takako Araki, Matthew A. Tyler, John T. Butterfield, Emiro Caicedo-Granados, Ramachandra P. Tummala
Publikováno v:
J Neurol Surg B Skull Base
Background Pituitary apoplexy after resection of giant pituitary adenomas is a rare but often cited morbidity associated with devastating outcomes. It presents as hemorrhage and/or infarction of residual tumor in the postoperative period. Because of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::745e08405b782d3f5c35a590becc8886
https://europepmc.org/articles/PMC9272256/
https://europepmc.org/articles/PMC9272256/
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Antibody-drug conjugates (ADC) increase the efficacy of current chemotherapeutics, decrease off site toxicity, and pair drug function with immunomodulatory effects. Current ADC platforms depend on the use of covalent linker molecules betwe
Autor:
Gregory J. Beilman, James V. Harmon, Victor Vakayil, John T. Butterfield, Keaton Joppru, Melena D. Bellin
Publikováno v:
Transplantation proceedings. 53(2)
Background Total pancreatectomy with islet autotransplantation is a therapeutic surgical option for patients with chronic pancreatitis leading to significant reduction in pain, improvement in quality of life, and potential for preservation of partial
Autor:
Shari L. Sutor, Elizabeth Ann L. Enninga, Alexey A. Leontovich, Thomas J. Flotte, Svetomir N. Markovic, Wendy K. Nevala, Kyriakos Chatzopoulos, John T. Butterfield
Publikováno v:
The Journal of Pathology. 245:468-477
In patients with metastatic melanoma, high blood levels of galectin-9 are correlated with worse overall survival and a bias towards a Th2 inflammatory state supportive of tumor growth. Although galectin-9 signaling through TIM3 on T cells has been de
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Antibody directed chemotherapy (ADC) takes advantage of the selectivity of the monoclonal antibody to increase the efficacy of the chemotherapeutic agent, while reducing toxicity. Previously we described three nab-paclitaxel (Abraxane) nanoparticles
Publikováno v:
Scientific Reports.
We developed a nano-antibody targeted chemotherapy (nATC) delivery strategy in which tumor specific and clinically relevant antibodies (rituximab, anti-CD20) are non-covalently bound to the albumin scaffold of nab-paclitaxel (ABX). We define the nano